WASHINGTON (AP) — For decades, patients seeking medication for pain have had two choices: over-the-counter drugs like aspirin or powerful prescription opioids like oxycodone. Opioid prescriptions have plummeted over the last decade as doctors have become more attuned to the risks of addiction and misuse during the country’s ongoing drug epidemic. Vertex Pharmaceuticals recently reported positive results for a non-opioid painkiller, one of several medications the Boston-based drugmaker has been developing for various forms of pain. Patients taking the drug after surgery experienced more pain relief than those getting a placebo, although the drug didn’t meet a secondary goal of outperforming treatment with an opioid. The Associated Press spoke with Vertex’s chief scientist Dr. David Altshuler about the company’s research and development plans. The interview has been edited for length and clarity. |
History weighs heavy on LionessesChinese auto industry hits milestones in 2023Chinese President Meets Red Cross PresidentOver 600 enterprises sign up for 7th CIIEXi Visits FloodXi Replies to Letter from Customs WorkersBohai oilfield hits record high in productionShanghai swoons over Federer again as legend holds courtSensing successChina launches new sea routes to South America as trade booms